Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Humoral Immune Responses01:36

Humoral Immune Responses

88.3K
Overview
88.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

824
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
824
Immunological Memory01:23

Immunological Memory

18.1K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
18.1K
Immunoprecipitation01:20

Immunoprecipitation

8.1K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
8.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

738
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
738

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying Japanese mothers of infants and toddlers at risk of parenting isolation: A validation study of cutoff scores and associated psychosocial measures.

Japan journal of nursing science : JJNSยท2026
Same author

First molecular evidence of reptile-associated Borrelia spp. in tortoise bont ticks (Amblyomma marmoreum) collected in Zambia.

Medical and veterinary entomologyยท2026
Same author

A Case of a Child With Persistent Cough Caused by Dental Aspiration.

Clinical case reportsยท2026
Same author

Detection of carbapenem resistance among third-generation cephalosporin-resistant Enterobacterales from small-scale poultry farms in peri-urban Lusaka, Zambia.

Access microbiologyยท2026
Same author

Presence or Emergence of Canine Leishmaniasis, Malawi.

Emerging infectious diseasesยท2026
Same author

Delayed Diagnosis of 48XXYY Syndrome: A Case Report Highlighting the Role of G-Banding Cytogenetics.

Journal of UOEHยท2025
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicineยท2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicineยท2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicineยท2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicineยท2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicineยท2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicineยท2019
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

19.6K

[Immunoglobulin therapy].

Shohei Ogata, Masahiro Ishii

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |December 19, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Kawasaki disease (KD) is an acute vasculitis affecting children. Intravenous immunoglobulin (IVIG) treats KD, but some patients are resistant, necessitating further research into IVIG mechanisms and alternative therapies.

    More Related Videos

    Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
    10:35

    Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

    Published on: December 26, 2017

    8.8K
    Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
    09:44

    Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

    Published on: January 29, 2019

    10.7K

    Related Experiment Videos

    Last Updated: Apr 19, 2026

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
    10:32

    Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

    Published on: June 5, 2015

    19.6K
    Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
    10:35

    Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

    Published on: December 26, 2017

    8.8K
    Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
    09:44

    Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

    Published on: January 29, 2019

    10.7K

    Area of Science:

    • Pediatric rheumatology
    • Immunology
    • Vascular biology

    Context:

    • Kawasaki disease (KD) is an acute, self-limited vasculitis affecting primarily infants and children.
    • Coronary artery (CA) aneurysms are a severe complication, occurring in 25% of untreated children.
    • Intravenous immunoglobulin (IVIG) is the standard treatment, reducing CA aneurysm incidence.

    Purpose:

    • To review the clinical utility of IVIG in Kawasaki disease.
    • To describe the proposed mechanisms of IVIG's anti-inflammatory activity in KD.
    • To highlight the challenges and implications of IVIG resistance in KD patients.

    Summary:

    • KD is an acute vasculitis with potential for severe coronary artery (CA) complications.
    • IVIG is effective in most KD cases, reducing CA aneurysms.
    • 10-20% of KD patients exhibit IVIG resistance, posing a higher risk for CA abnormalities.

    Impact:

    • Understanding IVIG mechanisms can optimize KD treatment strategies.
    • Identifying mechanisms of IVIG resistance may lead to improved therapies for non-responders.
    • This review provides insights into managing KD and preventing its severe cardiovascular sequelae.